Thomas L Vaughan
Thomas L Vaughan
Professor, University of Washington, Fred Hutchinson Cancer Research Center
Vahvistettu sähköpostiosoite verkkotunnuksessa u.washington.edu - Kotisivu
Nimike
Viittaukset
Viittaukset
Vuosi
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms
EM El-Omar, CS Rabkin, MD Gammon, TL Vaughan, HA Risch, ...
Gastroenterology 124 (5), 1193-1201, 2003
10662003
Population attributable risks of esophageal and gastric cancers
LS Engel, WH Chow, TL Vaughan, MD Gammon, HA Risch, JL Stanford, ...
Journal of the National Cancer Institute 95 (18), 1404-1413, 2003
7772003
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia
WH Chow, WJ Blot, TL Vaughan, HA Risch, MD Gammon, JL Stanford, ...
JNCI: Journal of the National Cancer Institute 90 (2), 150-155, 1998
7191998
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia
MD Gammon, H Ahsan, JB Schoenberg, AB West, H Rotterdam, S Niwa, ...
Journal of the National Cancer Institute 89 (17), 1277-1284, 1997
7121997
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma
WH Chow, MJ Blaser, WJ Blot, MD Gammon, TL Vaughan, HA Risch, ...
Cancer research 58 (4), 588-590, 1998
6631998
Epidemiology and pathogenesis of esophageal cancer
RS Holmes, TL Vaughan
Seminars in radiation oncology 17 (1), 2-9, 2007
6412007
Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma.
TL Vaughan, S Davis, A Kristal, DB Thomas
Cancer Epidemiology and Prevention Biomarkers 4 (2), 85-92, 1995
6351995
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
DC Farrow, TL Vaughan, PD Hansten, JL Stanford, HA Risch, ...
Cancer Epidemiology and Prevention Biomarkers 7 (2), 97-102, 1998
5521998
Nutrient intake and risk of subtypes of esophageal and gastric cancer
ST Mayne, HA Risch, R Dubrow, WH Chow, MD Gammon, TL Vaughan, ...
Cancer Epidemiology and Prevention Biomarkers 10 (10), 1055-1062, 2001
5512001
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis
BJ Reid, X Li, PC Galipeau, TL Vaughan
Nature reviews Cancer 10 (2), 87-101, 2010
3932010
Occupational exposure assessment in case–control studies: opportunities for improvement
K Teschke, AF Olshan, JL Daniels, AJ De Roos, CG Parks, M Schulz, ...
Occupational and environmental medicine 59 (9), 575-594, 2002
3932002
Central adiposity and risk of Barrett’s esophagus
ZR Edelstein, DC Farrow, MP Bronner, SN Rosen, TL Vaughan
Gastroenterology 133 (2), 403-411, 2007
3352007
Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus
RE Rudolph, TL Vaughan, BE Storer, RC Haggitt, PS Rabinovitch, ...
Annals of Internal Medicine 132 (8), 612-620, 2000
3232000
A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors
GL Hold, CS Rabkin, WH Chow, MG Smith, MD Gammon, HA Risch, ...
Gastroenterology 132 (3), 905-912, 2007
2982007
Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium
MB Cook, F Kamangar, DC Whiteman, ND Freedman, MD Gammon, ...
Journal of the National Cancer Institute 102 (17), 1344-1353, 2010
2772010
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer
DC Farrow, TL Vaughan, C Sweeney, MD Gammon, WH Chow, HA Risch, ...
Cancer Causes & Control 11 (3), 231-238, 2000
2772000
NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma
PC Galipeau, X Li, PL Blount, CC Maley, CA Sanchez, RD Odze, K Ayub, ...
PLoS medicine 4 (2), e67, 2007
2662007
Semen quality of men employed at a lead smelter.
BH Alexander, H Checkoway, C Van Netten, CH Muller, TG Ewers, ...
Occupational and Environmental Medicine 53 (6), 411-416, 1996
2511996
Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium
C Hoyo, MB Cook, F Kamangar, ND Freedman, DC Whiteman, ...
International journal of epidemiology 41 (6), 1706-1718, 2012
2392012
Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study
TL Vaughan, LM Dong, PL Blount, K Ayub, RD Odze, CA Sanchez, ...
The lancet oncology 6 (12), 945-952, 2005
2382005
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20